CAR T Cell Therapy in Solid Tumors
While CAR T cell therapy has demonstrated remarkable success in blood cancers, researchers are increasingly exploring its application in solid tumors. Solid tumors present unique challenges, including dense tumor microenvironments and immune evasion mechanisms.
Innovative strategies are being developed to improve T cell infiltration and persistence in solid tumor tissues. Techniques such as combining CAR T therapy with checkpoint inhibitors or engineering CAR T cells to resist immunosuppressive signals have shown promise in early studies.
The adaptation of CAR T therapy for solid tumors represents a major leap in immunotherapy. By overcoming the barriers posed by tumor microenvironments, scientists aim to extend the life-saving potential of CAR T therapy to a broader range of cancer patients.